Detalhe da pesquisa
1.
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity.
Immunity
; 52(5): 856-871.e8, 2020 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32289253
2.
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic.
Proc Natl Acad Sci U S A
; 118(26)2021 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172583
3.
Differential Interleukin-8 thresholds for chemotaxis and netosis in human neutrophils.
Eur J Immunol
; 51(9): 2274-2280, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33963542
4.
miR-216a Acts as a Negative Regulator of Breast Cancer by Modulating Stemness Properties and Tumor Microenvironment.
Int J Mol Sci
; 21(7)2020 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32230799
5.
Interleukin-18 in cancer immunology and immunotherapy.
Expert Opin Ther Targets
; 27(11): 1035-1042, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37993172
6.
Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies.
EMBO Mol Med
; 15(11): e17804, 2023 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37782273
7.
Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-ß antagonists.
Mol Ther Nucleic Acids
; 33: 668-682, 2023 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650116
8.
Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse models.
Oncoimmunology
; 12(1): 2147317, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36531687
9.
mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy.
Cell Rep Med
; : 100978, 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36933554
10.
Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic.
Oncoimmunology
; 12(1): 2197370, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37035637
11.
Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma.
Cell Rep Med
; 4(4): 101009, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37040772
12.
Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis.
J Immunother Cancer
; 11(11)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37918917
13.
Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity.
Cancer Immunol Res
; 11(2): 184-198, 2023 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36478221
14.
Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure.
Mol Ther Nucleic Acids
; 33: 599-616, 2023 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37637207
15.
Overcoming the limitations of cytokines to improve cancer therapy.
Int Rev Cell Mol Biol
; 369: 107-141, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777862
16.
Advances in mRNA-based drug discovery in cancer immunotherapy.
Expert Opin Drug Discov
; 17(1): 41-53, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496689
17.
Novel strategies exploiting interleukin-12 in cancer immunotherapy.
Pharmacol Ther
; 239: 108189, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35430292
18.
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies.
J Immunother Cancer
; 10(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35236742
19.
Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis.
Oncoimmunology
; 11(1): 2098657, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35859732
20.
Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy.
Cancer Res
; 82(23): 4373-4385, 2022 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130020